SLA Pipeline Town Hall Meeting
Christine Blazynski PhD
Sr. Vice-President
Product Development
An
informa business
www.citeline.com
Integrated and Enterprise-Wide Services
TrialTrove
Clinical Trials Intelligence
Global
Coverage
Of Clinical
Trials Design
and Status
Pipeline / Pharmaprojects
Drug Intelligence
World’s foremost
collection
of
All Drugs In
Development
From Bench
To Market
clinical trials,
investigators, sites,
drugs & analysis
SiteTrove
Investigator / Site Selection
Investigators
And Sites
Based Upon
Direct Trials
Experience
TrialPredict
Trials Timing / Benchmarking
Citeline Analytics
Mapping the Competition
Drug: Tykerb (Lapatinib)
Disease: Breast Cancer
Adjuvant and Neoadjuvant Therapy
2004
Map Date:
2005
2006
Competitive Development Map
2007
2008
2009
2010
2011
2012
2013
2014
Visualization of
Clinical
Development
Programs
6/23/07
Q1 Q2 Q3 Q4 Q1 Q2 Q3
Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Adjuvant
Lap (+ AC,Doxo,Pac,Tras), 0/I/II/III, TA109, #65110
Phase II
Lap, I/II/III, TA3000, TEACH, (#56312)
Phase III
Biomarker/Tox
Biomarker/SE, PGX
Lap (4-arm trial), I/II, TA8000, ALTTO, (#45399)
EI, Biomarker/SE, PGX
Lap (+/vs Tras, + AC,Doxo), I/II, #55823
Neoadjuvant
Phase II
Lap, II/III/IV, TA22-55, #33321
Biomarker/SE
Lap (+ Pac,Surg), III/IV,
PGX
AA50/TA60, #29064
Lap (+ Ab), I/II/III, TA30,
#50405
Lap, II/III, #51923
Biomarker/SE
Biomarker/SE
Lap, I/II/III, TA150, #52438
Citeline
Proprietary
Prediction of
Trials Enrollment
Timing
Lap, I/II/III, TA120,
Biomarker/SE
#45628
Lap (+ AC,Doc,Doxo), II/III, TA71, #60281 PGX
Lap (+/vs Tras, + Chemo), II/III, TA120,
#63895
Lap (+/vs Let), II/III, TA91, #63171
Phase III
Biomarker/SE
Biomarker/SE
Lap (+/vs Tras, + Pac), I/II, TA450, NEO-ALTTO, (#53035)
Biomarker/SE, PGX
PGX Lap (+/vs Tras, +AC,Doxo), II/III, TA522, #71240
An
informa business
NeoAdjuvant and Adjuvant
Phase II
Lap +Tras (+ AC,Doxo,Pac,Surg), 0/I/II/III, TA100, #70768 Biomarker/Tox
www.citeline.com
Depth and Breadth of Citeline Data
 150 countries covered
 180+ disease areas in TrialTrove/ >1000 in Pipeline
☐ 222 therapeutic categories in Pipeline




250+ analysts and editors
18,000 data sources
>4,000 companies developing therapeutics
>46,000 drugs
☐ Over 30 years of history
 >120,000 interventional trials
 >250,000 investigator profiles
An
informa business
www.citeline.com
Citeline’s Drug Intelligence
One centralized database of drug information
Deep integration with Citeline’s clinical development
offerings
An
informa business
www.citeline.com
Pharmaprojects
 Legacy pipeline database
☐ PJB publications
 Thirty-one continual years of tracking drug development
☐ Print
3rd party electronic distributer
delivery
☐ Updated once weekly
CD ROM
Web
 Trends data from 1995 through 2010
An
informa business
www.citeline.com
Pipeline
 Continually updated/real-time
 Clean, simple, user-friendly interface
 Customized alerts, saved searches, and share search
 Unlimited research support
 Search criteria expanded over time
 All fields export or disease-focused export
 Integration with TrialTrove, SiteTrove and TrialPredict
An
informa business
www.citeline.com
Export Options
An
informa business
www.citeline.com
An
informa business
www.citeline.com
 Recent Enhancements
☐ Hierarchical mechanism search
☐ Addition of biosimilars/biogenerics
☐ Company country HQ search and research focus
☐ Delivery route/medium/technology search
☐ Advanced search [phase 1]
☐ Automatic search for trials from multiple drug results
☐ Search by latest change date or range
An
informa business
www.citeline.com
Pipeline
An
informa business
www.citeline.com
Planned Enhancements
☐ Advanced Search: nested booleans, ability to move search terms, edit
operators within and between categories
☐ NCE search
☐ Search by chemical name
☐ Search by originator OR licensee
☐ Trial reporting: tabular view
☐ Dashboard reporting
An
informa business
www.citeline.com
700
Pipeline Users by Job Function
600
500
400
300
200
100
0
An
informa business
www.citeline.com
Citeline’s Drug Intelligence
One centralized database of drug information
Drug, company data to meet all business development
needs
An
informa business
www.citeline.com
Citeline - MedTrack




An
MedTrack joined Citeline in late March 2011. As of April 6:
☐ 21,326 companies
☐ 107,199 drugs (not all unique; includes generics)
☐ 1,556 drug delivery technologies
☐ 55,758 deals
☐ 642 indications
☐ 615,114 searchable news releases
☐ 142,525 management bios
☐ 481,558 searchable SEC documents
MedTrack V2 migration continues
Planning for initial integration between products just starting but clear
synergies exist
Need for market research and focus groups……… will you help?
informa business
www.citeline.com